Centiva Capital LP Buys Shares of 11,759 OrthoPediatrics Corp. (NASDAQ:KIDS)

Centiva Capital LP bought a new stake in OrthoPediatrics Corp. (NASDAQ:KIDS) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 11,759 shares of the company’s stock, valued at approximately $319,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Harbor Capital Advisors Inc. raised its position in OrthoPediatrics by 268.1% in the third quarter. Harbor Capital Advisors Inc. now owns 246,860 shares of the company’s stock valued at $6,692,000 after purchasing an additional 179,803 shares during the period. Paradigm Capital Management Inc. NY raised its holdings in shares of OrthoPediatrics by 8.0% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 134,400 shares of the company’s stock valued at $3,865,000 after buying an additional 10,000 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of OrthoPediatrics by 2.1% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 132,434 shares of the company’s stock valued at $3,590,000 after buying an additional 2,661 shares during the period. Mutual of America Capital Management LLC raised its holdings in shares of OrthoPediatrics by 195.1% in the 3rd quarter. Mutual of America Capital Management LLC now owns 107,609 shares of the company’s stock valued at $2,917,000 after buying an additional 71,146 shares during the period. Finally, Commonwealth Equity Services LLC raised its holdings in shares of OrthoPediatrics by 0.6% in the 2nd quarter. Commonwealth Equity Services LLC now owns 72,935 shares of the company’s stock valued at $2,098,000 after buying an additional 420 shares during the period. Hedge funds and other institutional investors own 69.05% of the company’s stock.

Analyst Ratings Changes

Several research firms recently issued reports on KIDS. Truist Financial cut their price objective on OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a report on Monday, October 14th. Needham & Company LLC reiterated a “buy” rating and issued a $42.00 price objective on shares of OrthoPediatrics in a report on Friday, November 8th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $50.00 price objective on shares of OrthoPediatrics in a report on Friday, September 13th.

OrthoPediatrics Trading Up 2.4 %

KIDS opened at $22.98 on Wednesday. OrthoPediatrics Corp. has a 12 month low of $21.55 and a 12 month high of $36.23. The stock has a market capitalization of $556.58 million, a price-to-earnings ratio of -18.68 and a beta of 1.14. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. The business has a fifty day moving average price of $25.67 and a 200 day moving average price of $28.67.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.